Authors: Jezersek, B Rudolf, Z Novakovic, S

Citation: B. Jezersek et al., The circulating auto-antibodies to p53 protein in the follow-up of lymphoma patients, ONCOL REP, 8(1), 2001, pp. 77-81

Authors: Sersa, G Stabuc, B Cemazar, M Miklavcic, D Rudolf, Z

Citation: G. Sersa et al., Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients, CLIN CANC R, 6(3), 2000, pp. 863-867

Authors: Sersa, G Stabuc, B Cemazar, M Miklavcic, D Rudolf, Z

Citation: G. Sersa et al., Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases, MELANOMA RE, 10(4), 2000, pp. 381-385

Authors: Ocvirk, J Stabuc, B Rudolf, Z Galvani, V Curin-Serbec, V

Citation: J. Ocvirk et al., Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients, MELANOMA RE, 10(3), 2000, pp. 253-258

Authors: Dolzan, V Rudolf, Z Breskvar, K

Citation: V. Dolzan et al., Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients, PFLUG ARCH, 439(3), 2000, pp. R29-R30

Authors: Bartenjev, I Rudolf, Z Stabuc, B Vrhovec, I Perkovic, T Kansky, A

Citation: I. Bartenjev et al., Cathepsin D expression in early cutaneous malignant melanoma, INT J DERM, 39(8), 2000, pp. 599-602